The University of Texas M. D. Anderson Cancer Center — Houston, Texas

Public research footprint of The University of Texas M. D. Anderson Cancer Center, compiled from the ClinicalTrials.gov public registry.

113

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Cancer · Breast Cancer · Refractory T-Cell Prolymphocytic Leukemia · Large B-cell Lymphoma

Recently updated registry entries

NCT07377526 — TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer (Suspended)
NCT06959537 — A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to… (Recruiting)
NCT07137481 — Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in… (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The University of Texas M. D. Anderson Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.